Risankizumab outperformed vedolizumab in various outcomes, including clinical response at 12 and 52 weeks, among patients ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

Lab monkeys thought to have COVID-19, hepatitis C virus and herpes escaped after the transport vehicle carrying them ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...

Use of teduglutide appeared safe for patients with short bowel syndrome, with no increased incidence of gastrointestinal ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

Adult patients with cancer who had adenomas at baseline and immune checkpoint inhibitor-mediated diarrhea and colitis faced a ...

Xiidra, usually prescribed for dry eye disease, led to significant improvements in contact lens discomfort and dryness within ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.The agency issued draft guidance that would simplify the study ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Patients with obesity and asthma who used GLP-1 receptor agonists had significantly fewer exacerbations and prednisone use ...

Progressive myopia is a growing issue in every country as near vision demands for children continue to increase. In 1980, ...